Literature DB >> 11686915

ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization.

A J Moss1, W Zareba, J Benhorin, J P Couderc, H Kennedy, E Locati-Heilbron, P Maison-Blanche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11686915      PMCID： PMC7027691          DOI： 10.1111/j.1542-474x.2001.tb00127.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


× No keyword cloud information.
  26 in total

1.  Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval.

Authors:  M Malik; P Färbom; V Batchvarov; K Hnatkova; A J Camm
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 2.  Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

Authors:  M Malik; A J Camm
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction.

Authors:  S Ahnve
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

4.  Evaluation of the spatial aspects of T-wave complexity in the long-QT syndrome.

Authors:  S G Priori; D W Mortara; C Napolitano; L Diehl; V Paganini; F Cantù; G Cantù; P J Schwartz
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

5.  Mutations in the hminK gene cause long QT syndrome and suppress IKs function.

Authors:  I Splawski; M Tristani-Firouzi; M H Lehmann; M C Sanguinetti; M T Keating
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

6.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

7.  Electrocardiographic quantitation of ventricular repolarization.

Authors:  M Merri; J Benhorin; M Alberti; E Locati; A J Moss
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

Review 8.  Measurement of the QT interval and the risk associated with QTc interval prolongation: a review.

Authors:  A J Moss
Journal:  Am J Cardiol       Date:  1993-08-26       Impact factor: 2.778

9.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

Authors:  A Sagie; M G Larson; R J Goldberg; J R Bengtson; D Levy
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

10.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome.

Authors:  Q Wang; J Shen; I Splawski; D Atkinson; Z Li; J L Robinson; A J Moss; J A Towbin; M T Keating
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582
View more
  11 in total

1.  New era for digital ECG: FDA requires digital ECG submission for tested drugs.

Authors:  Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-01       Impact factor: 1.468

2.  A renaissance in electrocardiography.

Authors:  Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

3.  Drug-induced QT prolongation: an update.

Authors:  Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

Review 4.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

5.  Choice of an alternative lead for QT interval measurement in serial ECGs when Lead II is not suitable for analysis.

Authors:  Vaibhav Salvi; Dilip R Karnad; Vaibhav Kerkar; Gopi Krishna Panicker; Deepak Manohar; Mili Natekar; Snehal Kothari; Dhiraj Narula; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2012-08-01

6.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

Review 7.  Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

Authors:  Fabrizio De Ponti; Elisabetta Poluzzi; Andrea Cavalli; Maurizio Recanatini; Nicola Montanaro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 8.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

Review 9.  Antipsychotic drugs and QT interval prolongation.

Authors:  Wojciech Zareba; David A Lin
Journal:  Psychiatr Q       Date:  2003

10.  False sense of safety by daily QTc interval monitoring during methadone IVPCA titration in a patient with chronic pain.

Authors:  Hector Miranda-Grajales; Joy Hao; Ricardo A Cruciani
Journal:  J Pain Res       Date:  2013-05-20       Impact factor: 3.133
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.